Research graph
References from Clinical Relevance of Increased Endothelial and Mesothelial Expression of Proangiogenic Proteases and VEGFA in the Omentum of Patients with Metastatic Ovarian High-Grade Serous Carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology
10.1016/s0020-7292(00)90001-8 · 2000 · External reference
Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis
10.1006/jsre.1996.4983 · 1997 · External reference
Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis
10.1016/s0022-4804(03)00307-x · 2003 · External reference
Inflamed tumor-associated adipose tissue is a depot for macrophages that stimulate tumor growth and angiogenesis
10.1007/s10456-012-9276-y · 2012 · External reference
Angiogenesis: update 2005
10.1111/j.1538-7836.2005.01361.x · 2005 · External reference
ECM and cell surface proteolysis: regulating cellular ecology
10.1016/s0092-8674(00)80429-8 · 1997 · External reference
MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D
10.1016/0014-4827(91)90362-x · 1991 · External reference
Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis
10.1016/s1535-6108(04)00111-4 · 2004 · External reference
Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases
10.1002/ijc.21421 · 2006 · External reference
Expression of vascular endothelial growth factor related to 72-kilodalton metalloproteinase immunostaining in patients with serous ovarian tumors
10.1002/(sici)1097-0142(19990515)85:10<2219::aid-cncr17>3.0.co;2-s · 1999 · External reference
The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer
10.1023/a:1008352502465 · 1999 · External reference
The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer
10.1111/j.1365-2362.2010.02305.x · 2010 · External reference
The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer
10.1158/1078-0432.ccr-05-2338 · 2006 · External reference
Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis
2011 · External reference
Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth
10.2353/ajpath.2006.051222 · 2006 · External reference
A note on Cohen's weighted kappa coefficient of agreement with linear weights
10.1016/j.stamet.2009.03.002 · 2009 · External reference
Unresolved reference
External reference
Modeling survival data: extending the Cox model
2000 · External reference
Unresolved reference
External reference
Residual-based tree-structured survival analysis
10.1002/sim.981 · 2002 · External reference
VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression
10.1038/sj.neo.7900186 · 2001 · External reference
Immunocytochemical localization of Cathepsin D and CA 125 in ovarian cancer
10.1016/s0020-7292(96)02792-0 · 1997 · External reference
Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis
10.1016/s0046-8177(00)80214-2 · 2000 · External reference
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours
2007 · External reference
Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer
1995 · External reference
Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms
1996 · External reference
Epithelial ovarian cancer-induced angiogenic phenotype of human omental microvascular endothelial cells may occur independently of VEGF signaling
10.1593/tlo.13529 · 2013 · External reference
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer
2001 · External reference
Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation
2003 · External reference
Induction of proteases in peritoneal carcinomatosis, the role of ICAM-1/CD43 interaction
10.1177/117727190700200001 · 2007 · External reference
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels
10.1016/s0959-8049(01)00235-0 · 2001 · External reference
Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis
10.1158/0008-5472.can-07-6276 · 2008 · External reference
Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis
10.1038/sj.onc.1205745 · 2002 · External reference
